Gene: TMEM40

55287
-
transmembrane protein 40
protein-coding
3p25.2
Ensembl:ENSG00000088726 Vega:OTTHUMG00000129801 UniprotKB:Q8WWA1
NC_000003.12
SNP Mapped
AD
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
2.321e-2 (AD)  2.041e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs9871587chr3:12755508 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg07908984chr3:12800836TMEM40Promoter2.342e-4Alcohol use disorders26763658

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
SPINK50.505
KRT780.475
MUC210.472
TMPRSS11B0.471
CEACAM50.461
DSG30.455
CRNN0.454
IVL0.449
SPRR1A0.448
TMPRSS11E0.446

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
C12orf40-0.228
CRYBB3-0.213
NPIPB15-0.204
VCX3A-0.199
STMND1-0.191
LENEP-0.187
ACAD11-0.186
OR6M1-0.185
PIRT-0.184
TP53TG3C-0.183

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0144643,4-dichloroaniline"3,4-dichloroaniline results in decreased expression of TMEM40 mRNA"24172598
C4727913-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of TMEM40 mRNA16788091
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM40 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM40 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM40 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM40 mRNA"27188386
D000082AcetaminophenAcetaminophen affects the expression of TMEM40 mRNA17562736
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of TMEM40 mRNA21641981|2210060
D017638Asbestos, Crocidolite"Asbestos, Crocidolite results in increased expression of TMEM40 mRNA"25351596
D001554BenzeneBenzene results in decreased expression of TMEM40 mRNA15929907
C006703benzo(b)fluoranthenebenzo(b)fluoranthene results in decreased expression of TMEM40 mRNA26377693
C022921benzo(k)fluoranthenebenzo(k)fluoranthene results in increased expression of TMEM40 mRNA26377693
D004958EstradiolEstradiol results in increased expression of TMEM40 mRNA19484750
C006780bisphenol Abisphenol A results in decreased expression of TMEM40 mRNA25181051
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMEM40 mRNA20938992
D003300Copper[NSC 689534 binds to Copper] which results in increased expression of TMEM40 mRNA20971185
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in increased expression of TMEM40 mRNA27392435
D002945CisplatinCisplatin results in increased expression of TMEM40 mRNA27392435
D004041Dietary Fats[Dietary Fats co-treated with resveratrol] results in increased expression of TMEM40 mRNA21852083
D002117CalcitriolCalcitriol results in increased expression of TMEM40 mRNA16002434
D004237DiuronDiuron metabolite results in decreased expression of TMEM40 mRNA24172598
D005472FluorouracilFluorouracil affects the expression of TMEM40 mRNA16584549
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMEM40 mRNA20938992
C039281furanfuran results in increased expression of TMEM40 mRNA27387713
D019833GenisteinGenistein results in decreased expression of TMEM40 mRNA20884965
D019833GenisteinGenistein results in increased expression of TMEM40 mRNA26865667
C544151jinfukang[Cisplatin co-treated with jinfukang] results in increased expression of TMEM40 mRNA27392435
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of TMEM40 mRNA25982114
C008261lead acetatelead acetate results in decreased expression of TMEM40 mRNA25270620
C042720mercuric bromidemercuric bromide results in increased expression of TMEM40 mRNA26272509
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM40 mRNA"27188386
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMEM40 mRNA20938992
C523799MRK 003TMEM40 results in increased susceptibility to MRK 00319903844
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in increased expression of TMEM40 mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of TMEM40 mRNA"25554681
C558013NSC 689534[NSC 689534 binds to Copper] which results in increased expression of TMEM40 mRNA20971185
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM40 mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of TMEM40 mRNA26272509
C059514resveratrol[Dietary Fats co-treated with resveratrol] results in increased expression of TMEM40 mRNA21852083
D012822Silicon DioxideSilicon Dioxide results in increased expression of TMEM40 mRNA22300531|2535159
C017947sodium arsenitesodium arsenite affects the methylation of TMEM40 gene28589171
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of TMEM40 mRNA27913140
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of TMEM40 mRNA21570461
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of TMEM40 mRNA27913140
C009495titanium dioxidetitanium dioxide results in decreased expression of TMEM40 mRNA23557971
D014635Valproic AcidValproic Acid results in increased expression of TMEM40 mRNA24383497

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
GO:0016021integral component of membrane-IEA-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal